SE9300971D0 - Hudvaardskomposition - Google Patents
HudvaardskompositionInfo
- Publication number
- SE9300971D0 SE9300971D0 SE19939300971A SE9300971A SE9300971D0 SE 9300971 D0 SE9300971 D0 SE 9300971D0 SE 19939300971 A SE19939300971 A SE 19939300971A SE 9300971 A SE9300971 A SE 9300971A SE 9300971 D0 SE9300971 D0 SE 9300971D0
- Authority
- SE
- Sweden
- Prior art keywords
- cyclodextrin
- conjugate
- vitamin
- beta
- derivative
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939300971A SE9300971D0 (sv) | 1993-03-24 | 1993-03-24 | Hudvaardskomposition |
PCT/SE1994/000235 WO1994021225A1 (en) | 1993-03-24 | 1994-03-17 | Skin care composition |
AU63884/94A AU6388494A (en) | 1993-03-24 | 1994-03-17 | Skin care composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939300971A SE9300971D0 (sv) | 1993-03-24 | 1993-03-24 | Hudvaardskomposition |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9300971D0 true SE9300971D0 (sv) | 1993-03-24 |
Family
ID=20389341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE19939300971A SE9300971D0 (sv) | 1993-03-24 | 1993-03-24 | Hudvaardskomposition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6388494A (sv) |
SE (1) | SE9300971D0 (sv) |
WO (1) | WO1994021225A1 (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5653971A (en) * | 1995-06-30 | 1997-08-05 | The Gillette Company | Shaving aid composite with an inclusion complex of a skin-soothing agent and a cyclodextrin |
DE19619990A1 (de) * | 1996-05-17 | 1997-11-20 | Charlotte Adler | Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung |
JP3940209B2 (ja) * | 1996-11-14 | 2007-07-04 | 株式会社資生堂 | 可溶化化粧料 |
SE520645C2 (sv) * | 1996-11-15 | 2003-08-05 | Interhealth Ab | Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav |
DE19713092A1 (de) * | 1997-03-27 | 1998-10-01 | Wacker Chemie Gmbh | Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung |
SE9801647D0 (sv) * | 1998-05-12 | 1998-05-12 | Interhealth Ab | Therapeutic composition |
KR100404868B1 (ko) * | 2000-03-28 | 2003-11-15 | 김삼 | 안정한 레티놀 팔미테이트 및 그를 함유하는 화장료 조성물 |
NO310176B1 (no) * | 2000-11-13 | 2001-06-05 | Wadlund As | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne |
DE10257246A1 (de) * | 2002-12-07 | 2004-06-24 | Beiersdorf Ag | Kosmetikum gegen Gesichtsglanz |
EP1641458A2 (en) * | 2002-12-27 | 2006-04-05 | Schering Aktiengesellschaft | Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors |
NO326950B1 (no) * | 2006-09-20 | 2009-03-16 | Pharma Medico Res Ltd | Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks |
NO20074043L (no) * | 2007-08-06 | 2009-02-09 | Spero As | Hudpleiende middel |
US8410079B2 (en) * | 2010-08-06 | 2013-04-02 | Island Kinetics | Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion |
US20140094433A1 (en) * | 2012-10-02 | 2014-04-03 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
US20140234433A1 (en) * | 2013-02-15 | 2014-08-21 | Nicholas V. Perricone | Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4371673A (en) * | 1980-07-21 | 1983-02-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble forms of retinoids |
FR2628973B1 (fr) * | 1988-03-25 | 1990-11-16 | Gattefosse Ets Sa | Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition |
AU616571B2 (en) * | 1988-10-28 | 1991-10-31 | Shiseido Company Ltd. | Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin |
FR2647015B1 (fr) * | 1989-05-17 | 1994-05-06 | Cird | Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique |
LU87843A1 (fr) * | 1990-11-15 | 1992-08-25 | Cird Galderma | Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique |
-
1993
- 1993-03-24 SE SE19939300971A patent/SE9300971D0/sv unknown
-
1994
- 1994-03-17 WO PCT/SE1994/000235 patent/WO1994021225A1/en active Application Filing
- 1994-03-17 AU AU63884/94A patent/AU6388494A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994021225A1 (en) | 1994-09-29 |
AU6388494A (en) | 1994-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9300971D0 (sv) | Hudvaardskomposition | |
CY1109869T1 (el) | Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης | |
FI956014A0 (sv) | Användning av nona- och dekapeptider för framställning av läkemedel för behandling av AIDS | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
EP0504938A3 (en) | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient | |
AU2905092A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
GR3019625T3 (en) | Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment | |
PT998287E (pt) | Utilizacao de levobupivacaina | |
MX9708800A (es) | Compuestos biciclicos aromaticos. | |
GB9103764D0 (en) | Compositions | |
WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
AU6924698A (en) | Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product | |
MY114716A (en) | Prophylactic and/or therapeutic treatment of dyspeptic symptoms | |
MX9708803A (es) | Compuestos biaromaticos de propinilo o dienilo. | |
TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
EP1304108A3 (en) | Anti-arrhythmic composition and methods of treatment | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
EP0821969A3 (en) | Medicinal Composition comprising TCF-II | |
EE9700231A (et) | Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks |